Petroleo Brasileiro Petrobras SA (ADR) (NYSE:PBR), the state-controlled Brazilian multinational oil company has cancelled its plans to sell debts in domestic and international markets later this year.
Petroleo Brasileiro Petrobras SA (ADR) (NYSE:PBR) shares after opening at $14.67 moved to $14.87 on last trade day and at the end of the day closed at $13.92. Company price to sales ratio in past twelve months was calculated as 0.65 and price to cash ratio as 3.56. Petroleo Brasileiro Petrobras SA (ADR) (NYSE:PBR) showed a positive weekly performance of 8.84%.
Gigamon (NASDAQ:GIMO) was downgraded by analysts at Pacific Crest from an “outperform” rating to a “sector perform” rating in a research report issued to clients and investors on Tuesday, Analyst Ratings Network.com reports. Gigamon Inc. (NYSE:GIMO) shares fell -33.93% in last trading session and ended the day on $17.31. GIMO return on equity ratio is recorded as -25.00% and its return on assets is -12.70%.
Inovio Pharmaceuticals Inc. (NYSEMKT:INO) has declared that post for the new VP for quality would be taken up by E.J. Inovio Pharmaceuticals Inc. (NYSEMKT:INO) shares moved down -5.41% in last trading session and was closed at $2.80, while trading in range of $2.79 – $3.08. Inovio Pharmaceuticals Inc. (NYSEMKT:INO) year to date (YTD) performance is -3.45%.
Alkermes Plc (NASDAQ:ALKS) said it planned to seek U.S. marketing approval for its experimental drug to treat the symptoms of schizophrenia after it succeeded in a late-stage study, sending the company’s shares up as much as 11 percent. Alkermes Plc (NASDAQ:ALKS) weekly performance is -6.96%. On last trading day company shares ended up $42.08. Alkermes Plc (NASDAQ:ALKS) distance from 50-day simple moving average (SMA50) is -12.01%. Analysts mean target price for the company is $50.00.